VITATOPS: A Study of VITAmins TO Prevent Stroke

Completed

Phase N/A Results

References

Related Links

Sources for Trial Information

VITATOPS
ClinicalTrials.gov

Staticmap?size=198x113&sensor=false&zoom=1&markers=52.0868, 5.18017&markers=22.3801, 114.201&markers=43.1163, 12.3875&markers=-36.8616, 174.77&markers=, &markers=40.1187, -75.1207&markers=33.9956, -81.0278&markers=34.0007, -81.0348&markers=-33.425, 151.342&markers=-33.933, 151.021&markers=-33.9203, 150.929&markers=-32.9227, 151.693&markers=-31.9504, 115.861&markers=-26.6213, 152.951&markers=-27.5128, 153.046&markers=-27.21, 153.116&markers=-42.8801, 147.33&markers=-37.8137, 145.119&markers=-37.4713, 144.785&markers=-37.8453, 144.982&markers=-37.4713, 144.785&markers=-27.6728, 121.628&markers=-32.0583, 115.752&markers=-31.9683, 115.815&markers=47.0778, 15

View Trial Locations

Recruitment

Enrollment: 8,000
Gender: Both
Minimum Age: N/A
Accepts Healthy Volunteers: No
111 locations, 20 countries

Principal Investigator

Graeme Hankey, MBBS/MD
Royal Perth Hospital / University of Western Australia
Ross Baker, MBBS/BMedSc
Royal Perth Hospital
John Eikelboom, MBBS/FRACP
Royal Perth Hospital

NCT00097669 ClinicalTrials.gov →